Diammonium glycyrrhizinate does not affect efficacy of adefovir dipivoxil therapy in patients with HBeAg-positive chronic hepatitis B

Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology

Volumn 21, Issue 3, 2007, Pages 270-272

  Li, Jun ^a   Zhao, Hong ^a   Si, Chong Wen ^a   Zhang, Yue Xin ^a   Chen, Xin Yue ^a   Wang, Lei ^a   Tang, Xiao Ping ^a   Lei, Chun Liang ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ADENINE; ANTIVIRUS AGENT; DRUG DERIVATIVE; GLYCYRRHIZIC ACID; HEPATITIS B(E) ANTIGEN; PHOSPHONIC ACID DERIVATIVE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIROLOGY;

ADENINE; ADULT; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; GLYCYRRHIZIC ACID; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; PHOSPHONIC ACIDS; TREATMENT OUTCOME;

EID: 58149329168     PISSN: 10039279     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)